What was once a clinical breakthrough for diabetes has evolved into a complex financial and governance challenge for 2026 Between the skyrocketing demand for GLP-1s (like Wegovy and Zepbound), the Trump Administrations drug-pricing agenda, and a push for PBM transparency, HR and benefits leaders are standing at a crossroads
Notably, weight-specific patterns emerged in serious adverse events: papillary thyroid carcinoma demonstrated significantly higher incidence in the high-weight cohort compared to other groups (p 360 days)
doi: 10.3233/JAD-215376, PMID: [DOI] [PubMed] [Google Scholar] 84.Tang S, Xu S, Lu X, Gullapalli RP, McKenna MC, Waddell J
Effects of a supplement containing apoaequorin on verbal learning in older adults in the community
Five-m-thick sections were cut from paraffin blocks onto Xenium slides under RNAse-free conditions (10X Genomics, PN-1000460) and submitted to the University of Michigan Advanced Genomics Core for processing and image acquisition using the Xenium Analyzer (10X Genomics, PN-1000481)